Launching May 18, 2026 · Geneva
When war closes doors,
we open corridors
A global network connecting cancer patients in conflict zones to treatment centers worldwide.
A global network connecting cancer patients in conflict zones to treatment centers worldwide.
For more than a million cancer patients living inside conflict zones, the obstacle is not the absence of treatment — it is the absence of a path to reach it. Chemotherapy interrupted by bombardment. Children with curable cancers who cannot cross a border. Oncologists who have fled. Hospitals destroyed.
"No patient should die of a curable cancer because a war stood in the way. We have the treatments. We have the hospitals. We just need to connect them to the people who need them."OncoCorridor Founding Statement
Chemotherapy and radiotherapy require continuity. A single interruption caused by bombardment or supply failure can render months of treatment ineffective — and cause direct harm.
Hospitals are disproportionately targeted in modern conflicts. Oncology units — dependent on complex equipment, cold chains, and specialist staff — are among the first to cease functioning.
Remarkable work has been done by individual organizations. But no coordinated global mechanism exists to systematically connect treatment capacity to patients in conflict zones — until now.
OncoCorridor is not a declaration — it is infrastructure. A living network connecting patients to treatment centers through a professional, full-time secretariat.
Cancer centers worldwide commit named patient slots per year — specific capacity, real commitment, trackable delivery.
Physicians in conflict zones submit referrals through the secure OncoCorridor platform. No bureaucratic barriers.
Full-time staff match patients to centers and coordinate travel, visas, medical records, and continuity of care.
Patients receive care. Outcomes are tracked. Every case strengthens the network and expands its reach.
Our work has been recognized in one of the world's leading oncology journals.
Over 2 billion people currently reside in conflict-affected areas. For millions of people affected by cancer in these areas, disruptions in health services lead to treatment delays or interruptions and, ultimately, amenable deaths. That people should endure both conflict and avoidable cancer death is a double injustice our professional oaths oblige us to confront.
The OncoCorridor initiative, led by OncoDaily and the Institute of Cancer and Crisis, aims to reduce avoidable deaths from people diagnosed with cancer in conflict-affected regions by establishing a global network that connects them with treatment centres worldwide.
Distinguished leaders and experts who will be speaking at the OncoCorridor launch and throughout our initiative.
Editor-in-chief of OncoDaily, President, SIOP Asia Continental Branch, President, POEM Group, Co-Chair, St. Jude Global EURO Regional Advisory Committee
Humanitarian and Global Health Leader
Minister of Health of Syria
President-Elect, Union for International Cancer Control (UICC)
Chair of the Committee on National Health, Medical Care and Health Insurance
Head of Cancer Team, World Health Organization
CEO, Union for International Cancer Control (UICC)
Director, Institute of Cancer Policy, King's College London
Professor of Oncology, University of Toronto and University of Nairobi
President of ISOPT; Past-President of City of Hope; Past CEO of ASCO
Director of Cancer Disease Directorate, Ministry of Health of Syria
Deputy Chairman of the Board of Swiss Medical Network
Regional Adviser for NCD Prevention and Health Care, WHO EMRO
CEO, City Cancer Challenge
CEO, Aladina Foundation
CEO, The Max Foundation
Senior Advisor for Clinical Research, National Cancer Institute's Center for Global Health
Meet the team of oncologists, researchers, and humanitarian leaders driving the OncoCorridor initiative.
Dr. Jemma Arakelyan is a medical oncologist committed to improving cancer care for underserved populations. Her work focuses on the intersection of oncology, humanitarian action, and research.
Dr. Emma Tadevosyan works to advance high-quality and equitable cancer treatment in low- and middle-income countries. At the City of Smile Foundation, she leads pediatric and adolescent and young adult (AYA) cancer programs in Armenia.
Marium Husain is passionate about oncology, humanitarian medicine, and improving care for vulnerable populations.
"I had read an article about doctors without borders and the amazing work they do. I was also passionate about Oncology care... I’m so grateful to be connected with Jemma and learn about OncoCorridor. It allows me to achieve my goal of helping those most vulnerable dealing with the most serious health issues."
"I joined OncoCorridor to be part of an initiative that is at the core of deriving an influential platform actively connecting patients in conflict zones to appropriate cancer treatment. I hope to contribute to efforts to diminish barriers..."
"OncoCorridor has the potential to provide life changing opportunities for people already enduring enormous hardship. As a volunteer, I hope to be part of making these opportunities possible, and contribute meaningfully to global public health."
Gohar Geghamyan works in oncology research and is committed to contributing to better cancer care and patient support.
"I love taking on new challenges and opportunities that allow me to contribute to the oncology field. As a cancer survivor, this is my way of giving back to the community that once helped me fight my own battle."
Shirin Geranmayeh is affiliated with the University of Alberta and brings an academic and research perspective to the OncoCorridor team.
"To contribute to reducing healthcare inequalities and improving access to cancer treatment for patients facing barriers to care."
Explore our full playlist of interviews, panel discussions, and project updates.
Watch all official interviews, discussions, and updates on YouTube.
OncoCorridor is the direct operationalization of a landmark manifesto published in The Lancet — co-authored by the WHO Director-General — calling for exactly this kind of working mechanism.
"A manifesto on improving cancer care in conflict-impacted populations"
Tedros Adhanom Ghebreyesus et al. · DOI: 10.1016/S0140-6736(24)01023-7
OncoCorridor launches on the opening day of the 79th World Health Assembly — the highest-level global health gathering on earth. Founding members, pledging centers, and partner organizations will be announced before the international health community.
If your institution is ready to pledge patient capacity and be part of the founding, we want to hear from you now.
Pledge Your InstitutionEvery institution that joins brings more patients through. Every government that endorses removes another barrier.
Receive launch updates, pledge opportunities, and information on how to participate in Geneva.
Write directly: secretariat@oncocorridor.org